Luis Fernando Gomes Moreira, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutrition Assessment | 6 | 2019 | 725 | 2.610 |
Why?
|
| Stomach Neoplasms | 8 | 2021 | 1422 | 1.660 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2018 | 951 | 1.330 |
Why?
|
| Malnutrition | 4 | 2018 | 637 | 0.860 |
Why?
|
| Nutritional Status | 3 | 2018 | 1604 | 0.710 |
Why?
|
| Esophageal Neoplasms | 4 | 2018 | 1655 | 0.660 |
Why?
|
| Critical Illness | 4 | 2019 | 2703 | 0.630 |
Why?
|
| Peritoneal Lavage | 1 | 2018 | 31 | 0.630 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2018 | 336 | 0.560 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 6312 | 0.530 |
Why?
|
| Bone Transplantation | 3 | 2009 | 914 | 0.520 |
Why?
|
| Ultrasonography, Mammary | 1 | 2017 | 247 | 0.510 |
Why?
|
| Appendectomy | 1 | 2018 | 431 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2018 | 729 | 0.470 |
Why?
|
| Dietary Fiber | 1 | 2018 | 760 | 0.470 |
Why?
|
| Gastrectomy | 2 | 2021 | 668 | 0.450 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 782 | 0.410 |
Why?
|
| Appendicitis | 1 | 2018 | 674 | 0.390 |
Why?
|
| Eating | 1 | 2018 | 1537 | 0.380 |
Why?
|
| Acetabulum | 3 | 2009 | 541 | 0.370 |
Why?
|
| Rectal Neoplasms | 4 | 2006 | 1152 | 0.350 |
Why?
|
| Critical Care | 2 | 2019 | 2692 | 0.340 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2018 | 4030 | 0.320 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 185 | 0.310 |
Why?
|
| Perioperative Care | 1 | 2016 | 1030 | 0.310 |
Why?
|
| Intensive Care Units | 2 | 2018 | 3730 | 0.300 |
Why?
|
| Osseointegration | 1 | 2009 | 273 | 0.300 |
Why?
|
| Bone Substitutes | 1 | 2008 | 233 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2018 | 1400 | 0.270 |
Why?
|
| Materials Testing | 1 | 2008 | 855 | 0.250 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15662 | 0.240 |
Why?
|
| Freeze Drying | 3 | 2009 | 100 | 0.240 |
Why?
|
| Prognosis | 9 | 2018 | 29559 | 0.220 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 670 | 0.220 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5499 | 0.210 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4922 | 0.210 |
Why?
|
| Postoperative Period | 2 | 2018 | 1823 | 0.210 |
Why?
|
| Risk Assessment | 3 | 2019 | 24049 | 0.210 |
Why?
|
| Middle Aged | 22 | 2018 | 219628 | 0.200 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 58864 | 0.190 |
Why?
|
| Esophagus | 1 | 2007 | 1023 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2016 | 4626 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1405 | 0.170 |
Why?
|
| Brazil | 3 | 2021 | 1211 | 0.170 |
Why?
|
| Aged | 15 | 2018 | 168615 | 0.160 |
Why?
|
| Length of Stay | 3 | 2018 | 6452 | 0.160 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 2524 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 2925 | 0.160 |
Why?
|
| Male | 23 | 2018 | 358602 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2018 | 54190 | 0.150 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 351 | 0.150 |
Why?
|
| Diet | 1 | 2016 | 8001 | 0.150 |
Why?
|
| Female | 22 | 2018 | 390174 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11046 | 0.150 |
Why?
|
| Neoplasms | 2 | 2017 | 22023 | 0.150 |
Why?
|
| Humans | 32 | 2021 | 759098 | 0.140 |
Why?
|
| Femoral Neck Fractures | 1 | 2018 | 141 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3614 | 0.140 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 275 | 0.140 |
Why?
|
| Adult | 14 | 2018 | 219353 | 0.140 |
Why?
|
| Survival Rate | 3 | 2018 | 12793 | 0.130 |
Why?
|
| Translations | 1 | 2016 | 80 | 0.130 |
Why?
|
| Thumb | 1 | 2018 | 232 | 0.130 |
Why?
|
| Weight Loss | 2 | 2018 | 2673 | 0.130 |
Why?
|
| Survival | 1 | 2015 | 161 | 0.120 |
Why?
|
| Cattle | 3 | 2009 | 3844 | 0.120 |
Why?
|
| Cultural Characteristics | 1 | 2016 | 254 | 0.120 |
Why?
|
| Lymph Node Excision | 2 | 2021 | 1304 | 0.120 |
Why?
|
| Neoplasm Staging | 4 | 2020 | 11125 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2018 | 768 | 0.120 |
Why?
|
| Osteoarthritis, Hip | 1 | 2018 | 409 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5312 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2018 | 25853 | 0.110 |
Why?
|
| Organ Size | 1 | 2018 | 2247 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2018 | 629 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1340 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15262 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 577 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2018 | 80125 | 0.090 |
Why?
|
| Outpatients | 1 | 2018 | 1601 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 21019 | 0.090 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2009 | 76 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2012 | 675 | 0.080 |
Why?
|
| Toxicity Tests | 1 | 2008 | 111 | 0.080 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 225 | 0.080 |
Why?
|
| Acute Disease | 1 | 2018 | 7247 | 0.070 |
Why?
|
| Immune System Diseases | 1 | 2010 | 258 | 0.070 |
Why?
|
| Anthropometry | 1 | 2012 | 1344 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21992 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2018 | 10181 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2018 | 2156 | 0.070 |
Why?
|
| Hand | 1 | 2012 | 903 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2009 | 697 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39213 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2018 | 8530 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2007 | 657 | 0.060 |
Why?
|
| Femur | 1 | 2009 | 1300 | 0.050 |
Why?
|
| Cytogenetic Analysis | 1 | 2003 | 271 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2012 | 2256 | 0.050 |
Why?
|
| Risk Factors | 4 | 2018 | 74167 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2649 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14648 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18391 | 0.050 |
Why?
|
| Chromatin | 2 | 2003 | 2940 | 0.050 |
Why?
|
| Consensus | 2 | 2021 | 3091 | 0.050 |
Why?
|
| Radiography | 2 | 2009 | 6964 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15815 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 20027 | 0.040 |
Why?
|
| Reoperation | 1 | 2009 | 4286 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2979 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10746 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 3618 | 0.040 |
Why?
|
| Rectum | 1 | 2003 | 896 | 0.040 |
Why?
|
| Alcohol Drinking | 2 | 2007 | 4006 | 0.040 |
Why?
|
| Cell Survival | 1 | 2006 | 5793 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6770 | 0.030 |
Why?
|
| Cell Line | 1 | 2008 | 15638 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2912 | 0.030 |
Why?
|
| Smoking | 2 | 2007 | 9066 | 0.030 |
Why?
|
| Carcinoma | 1 | 2003 | 2335 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 58477 | 0.020 |
Why?
|
| Apoptosis | 1 | 2006 | 9470 | 0.020 |
Why?
|
| Portugal | 1 | 2010 | 90 | 0.020 |
Why?
|
| Child | 1 | 2017 | 79604 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 87551 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 9372 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11903 | 0.020 |
Why?
|
| Animals | 3 | 2009 | 167531 | 0.020 |
Why?
|
| Quality of Life | 1 | 2010 | 13285 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 9271 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40083 | 0.020 |
Why?
|
| Computers | 1 | 2010 | 595 | 0.020 |
Why?
|
| Bone Density | 1 | 2018 | 3517 | 0.020 |
Why?
|
| Iodides | 1 | 2005 | 39 | 0.020 |
Why?
|
| Esophagitis | 1 | 2005 | 164 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 17748 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2005 | 561 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 2008 | 917 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 80993 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12871 | 0.010 |
Why?
|
| Joint Instability | 1 | 2008 | 794 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4668 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5192 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2010 | 9245 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3020 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 64867 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 8936 | 0.000 |
Why?
|